METabolic EXplorer gained over 9% on the Paris Bourse on Monday, after announcing the finalization of operations to finance its 2023-2024 strategic plan.

The industrial fermentation specialist recalls that this agreement, initially announced last December, aims to finance the transformation of the Amiens plant towards specialty amino acids, its new core business.

The financing plan includes a capital increase with shareholders' preferential subscription rights for an amount of eight million euros.

It also includes the issue of straight bonds to Bpifrance, the Group's reference shareholder, for a principal amount of 12 million euros.

The program also includes a state-guaranteed loan for a total principal amount of 33.9 million euros, as well as the provision by banking partners of a new medium-term loan for a principal amount of around 15.5 million euros.

Finally, MetEx has mandated a service provider to find additional financing for the business plan to be put in place by January 2025, up to a maximum of 30 million euros.

Following the issue of new shares as part of the capital increase, Bpifrance's stake has risen from 25.9% to 30.1% of the capital.

Copyright (c) 2023 CercleFinance.com. All rights reserved.